INNT
TOTAL INVALIDATION PROCESSED BY THE IB
11/01/2024
Back to search
Official data from USPTO
VYNOVLI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
11/01/2024
Trademark type
Word
Nice classes
5
Filing date
11/17/2016
Registration date
06/06/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/22/2023
Last transaction
12/22/2023
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH
Examiner
COLEMAN, CIMMERIAN
Law office
L20
Current location
TMEG LAW OFFICE 102
Holders and representatives
Holders
NOVARTIS AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology ; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publications
History of USPTO decisions and trademark events.
33 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/04/2024
INPC
INVALIDATION PROCESSED
09/04/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/23/2024
C71T
CANCELLED SECTION 71
12/22/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/06/2022
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
11/30/2018
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
10/31/2018
INPC
INVALIDATION PROCESSED
10/31/2018
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
10/20/2018
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
02/27/2018
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
02/20/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/20/2018
GPNX
NOTIFICATION PROCESSED BY IB
07/28/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/07/2017
FIMP
FINAL DISPOSITION PROCESSED
07/07/2017
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
07/06/2017
ES7R
TEAS SECTION 7 REQUEST RECEIVED
07/05/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/01/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/01/2017
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
06/30/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
06/06/2017
PUBO
PUBLISHED FOR OPPOSITION
03/21/2017
GPNX
NOTIFICATION PROCESSED BY IB
03/17/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/01/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/01/2017
NPUB
NOTICE OF PUBLICATION
03/01/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/08/2017
DOCK
ASSIGNED TO EXAMINER
02/08/2017
MAFR
APPLICATION FILING RECEIPT MAILED
01/21/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/17/2017
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
01/13/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/05/2017
Continuous trademark protection
Get notified about every new filing that threatens VYNOVLI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.